Published in Mol Psychiatry on March 03, 2009
BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases. Nat Rev Neurosci (2013) 1.91
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis. Nat Rev Neurol (2014) 1.46
Association of functional polymorphisms from brain-derived neurotrophic factor and serotonin-related genes with depressive symptoms after a medical stressor in older adults. PLoS One (2015) 1.42
Predicting Response Trajectories during Cognitive-Behavioural Therapy for Panic Disorder: No Association with the BDNF Gene or Childhood Maltreatment. PLoS One (2016) 1.38
Variant brain-derived neurotrophic factor Val66Met endophenotypes: implications for posttraumatic stress disorder. Ann N Y Acad Sci (2010) 1.35
Huntington's disease: the case for genetic modifiers. Genome Med (2009) 1.25
Genetics of Obesity: What have we Learned? Curr Genomics (2011) 1.19
Interaction between stress and the BDNF Val66Met polymorphism in depression: a systematic review and meta-analysis. BMC Med (2014) 1.14
Variant brain-derived neurotrophic factor (Valine66Methionine) polymorphism contributes to developmental and estrous stage-specific expression of anxiety-like behavior in female mice. Biol Psychiatry (2012) 1.05
BDNF Val66Met and cognition: all, none, or some? A meta-analysis of the genetic association. Genes Brain Behav (2011) 1.03
The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility: progress and controversy. Mol Psychiatry (2015) 1.02
Polymorphisms in BDNF (Val66Met) and 5-HTTLPR, morning cortisol and subsequent depression in at-risk adolescents. Br J Psychiatry (2010) 1.01
Allelic differences between Europeans and Chinese for CREB1 SNPs and their implications in gene expression regulation, hippocampal structure and function, and bipolar disorder susceptibility. Mol Psychiatry (2013) 0.97
From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatment. Can J Psychiatry (2014) 0.93
Variants in doublecortin- and calmodulin kinase like 1, a gene up-regulated by BDNF, are associated with memory and general cognitive abilities. PLoS One (2009) 0.92
Variability in Dopamine Genes Dissociates Model-Based and Model-Free Reinforcement Learning. J Neurosci (2016) 0.91
BDNF Val(66)Met genotype is associated with drug-seeking phenotypes in heroin-dependent individuals: a pilot study. Addict Biol (2012) 0.89
Brain-derived neurotrophic factor gene Val66Met polymorphism modulates reversible cerebral vasoconstriction syndromes. PLoS One (2011) 0.89
The BDNF Valine 68 to Methionine Polymorphism Increases Compulsive Alcohol Drinking in Mice That Is Reversed by Tropomyosin Receptor Kinase B Activation. Biol Psychiatry (2015) 0.87
The brain-derived neurotrophic factor Val66Met polymorphism moderates early deprivation effects on attention problems. Dev Psychopathol (2012) 0.87
Polymorphisms in the brain-derived neurotrophic factor gene influence memory and processing speed one month after brain injury. J Neurotrauma (2012) 0.86
Antidepressant mechanism of ketamine: perspective from preclinical studies. Front Neurosci (2015) 0.85
Altered white matter architecture in BDNF met carriers. PLoS One (2013) 0.85
A neurogenetics approach to defining differential susceptibility to institutional care. Int J Behav Dev (2015) 0.82
BDNF polymorphism predicts the rate of decline in skilled task performance and hippocampal volume in healthy individuals. Transl Psychiatry (2011) 0.81
Association of brain-derived neurotrophic factor gene Val66Met polymorphism with primary dysmenorrhea. PLoS One (2014) 0.81
Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction. Pharmacogenomics (2013) 0.80
The serotonin transporter linked polymorphic region and brain-derived neurotrophic factor valine to methionine at position 66 polymorphisms and maternal history of depression: associations with cognitive vulnerability to depression in childhood. Dev Psychopathol (2013) 0.80
Lack of an association of BDNF Val66Met polymorphism and plasma BDNF with hippocampal volume and memory. Cogn Affect Behav Neurosci (2015) 0.80
The Effect of Exercise Training on Resting Concentrations of Peripheral Brain-Derived Neurotrophic Factor (BDNF): A Meta-Analysis. PLoS One (2016) 0.79
Shame and Guilt-Proneness in Adolescents: Gene-Environment Interactions. PLoS One (2015) 0.79
Association of BDNF and COMT genotypes with cognitive processing of anti-smoking PSAs. Genes Brain Behav (2011) 0.78
Association between brain-derived neurotrophic factor genetic polymorphism Val66Met and susceptibility to bipolar disorder: a meta-analysis. BMC Psychiatry (2014) 0.78
Association between BDNF gene polymorphisms and serotonergic activity using loudness dependence of auditory evoked potentials in healthy subjects. PLoS One (2013) 0.78
Association between the brain-derived neurotrophic factor Val66Met polymorphism and therapeutic response to olanzapine in schizophrenia patients. Psychopharmacology (Berl) (2014) 0.77
BDNF Val66Met genotype determines hippocampus-dependent behavior via sensitivity to glucocorticoid signaling. Mol Psychiatry (2015) 0.77
BDNF Val66Met polymorphism and antipsychotic-induced tardive dyskinesia occurrence and severity: a meta-analysis. Schizophr Res (2014) 0.76
Activation of a synapse weakening pathway by human Val66 but not Met66 pro-brain-derived neurotrophic factor (proBDNF). Pharmacol Res (2015) 0.76
Effects of the BDNF Val66Met Polymorphism on Gray Matter Volume in Typically Developing Children and Adolescents. Cereb Cortex (2016) 0.76
Neurotrophic tyrosine kinase receptor type 2 (NTRK2) gene associated with treatment response to mood stabilizers in patients with bipolar I disorder. J Mol Neurosci (2013) 0.76
Allelic distribution of BDNF Val66Met polymorphism in healthy Romanian volunteers. Transl Neurosci (2016) 0.75
Explore the Features of Brain-Derived Neurotrophic Factor in Mood Disorders. PLoS One (2015) 0.75
Possible associations of NTRK2 polymorphisms with antidepressant treatment outcome: findings from an extended tag SNP approach. PLoS One (2013) 0.75
BDNF Val66Met Polymorphism as a Moderator of Exercise Enhancement of Smoking Cessation Treatment in Anxiety Vulnerable Adults. Ment Health Phys Act (2016) 0.75
Association between obesity and the brain-derived neurotrophic factor gene polymorphism Val66Met in individuals with bipolar disorder in Mexican population. Neuropsychiatr Dis Treat (2016) 0.75
Serum brain-derived neurotrophic factor (BDNF) across pregnancy and postpartum: Associations with race, depressive symptoms, and low birth weight. Psychoneuroendocrinology (2016) 0.75
Missense Mutation of Brain Derived Neurotrophic Factor (BDNF) Alters Neurocognitive Performance in Patients with Mild Traumatic Brain Injury: A Longitudinal Study. PLoS One (2016) 0.75
Potential unfavorable impacts of BDNF Val66Met polymorphisms on metabolic risks in average population in a longevous area. BMC Geriatr (2017) 0.75
The Role of BDNF in the Development of Fear Learning. Depress Anxiety (2016) 0.75
A sexually dimorphic pre-stressed translational signature in CA3 pyramidal neurons of BDNF Val66Met mice. Nat Commun (2017) 0.75
Peripheral Brain-Derived Neurotrophic Factor Levels in Alzheimer's Disease and Mild Cognitive Impairment: a Comprehensive Systematic Review and Meta-analysis. Mol Neurobiol (2016) 0.75
Evidence of associations between brain-derived neurotrophic factor (BDNF) serum levels and gene polymorphisms with tinnitus. Noise Health (2017) 0.75
The BDNF Val(66)Met polymorphism is associated with structural neuroanatomical differences in young children. Behav Brain Res (2017) 0.75
A haplotype map of the human genome. Nature (2005) 105.70
The structure of haplotype blocks in the human genome. Science (2002) 50.88
Detecting recent positive selection in the human genome from haplotype structure. Nature (2002) 22.00
A human genome diversity cell line panel. Science (2002) 14.11
Centre d'etude du polymorphisme humain (CEPH): collaborative genetic mapping of the human genome. Genomics (1990) 13.23
Positive natural selection in the human lineage. Science (2006) 12.55
The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell (2003) 12.50
Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science (2006) 5.89
Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci (2003) 5.11
The yin and yang of neurotrophin action. Nat Rev Neurosci (2005) 4.45
Estimating F-statistics. Annu Rev Genet (2002) 4.30
A comprehensive human linkage map with centimorgan density. Cooperative Human Linkage Center (CHLC). Science (1994) 4.02
Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry (2002) 3.78
Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci (2004) 3.47
Association of a functional BDNF polymorphism and anxiety-related personality traits. Psychopharmacology (Berl) (2005) 1.77
Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol Psychiatry (2005) 1.61
Brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity. Ann N Y Acad Sci (2007) 1.51
Association between BDNF val66 met genotype and episodic memory. Am J Med Genet B Neuropsychiatr Genet (2005) 1.36
Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. Am J Hum Genet (2003) 1.32
Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients. Bipolar Disord (2003) 1.24
BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol Psychiatry (2005) 1.22
Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations. Hum Mol Genet (2004) 1.20
Association of BDNF with restricting anorexia nervosa and minimum body mass index: a family-based association study of eight European populations. Eur J Hum Genet (2005) 1.13
Met66 in the brain-derived neurotrophic factor (BDNF) precursor is associated with anorexia nervosa restrictive type. Mol Psychiatry (2003) 1.09
Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene. Psychiatry Clin Neurosci (2006) 1.01
Association between the BDNF gene and schizophrenia. Mol Psychiatry (2003) 0.99
Genetics of bipolar disorder: focus on BDNF Val66Met polymorphism. Novartis Found Symp (2008) 0.98
Effect of the BDNF Val66Met genotype on episodic memory in schizophrenia. Schizophr Res (2005) 0.97
A complex polymorphic region in the brain-derived neurotrophic factor (BDNF) gene confers susceptibility to bipolar disorder and affects transcriptional activity. Mol Psychiatry (2006) 0.94
Investigating the role of the brain-derived neurotrophic factor (BDNF) val66met variant in obsessive-compulsive disorder (OCD). World J Biol Psychiatry (2008) 0.90
Brain-derived neurotrophic factor gene and schizophrenia: polymorphism screening and association analysis. Schizophr Res (2003) 0.90
Extensive genotyping of the BDNF and NTRK2 genes define protective haplotypes against obsessive-compulsive disorder. Biol Psychiatry (2007) 0.90
The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with risk for psychosis: evidence from a family-based association study. Am J Med Genet B Neuropsychiatr Genet (2006) 0.88
Brain-derived neurotrophic factor and risk of schizophrenia: an association study and meta-analysis. Biochem Biophys Res Commun (2006) 0.86
Dinucleotide repeat polymorphism at the human gene for the brain-derived neurotrophic factor (BDNF). Hum Mol Genet (1992) 0.86
BDNF Met66 allele is associated with anorexia nervosa in the Polish population. Psychiatr Genet (2007) 0.81
Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23
Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet (1999) 24.24
High-resolution haplotype structure in the human genome. Nat Genet (2001) 20.51
Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science (1998) 18.23
Linkage disequilibrium in the human genome. Nature (2001) 17.24
Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat Genet (1999) 17.09
The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet (2000) 15.19
A gene map of the human genome. Science (1996) 14.32
Positive natural selection in the human lineage. Science (2006) 12.55
De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry (2011) 4.91
Determination of ancestral alleles for human single-nucleotide polymorphisms using high-density oligonucleotide arrays. Nat Genet (1999) 4.79
Large-scale discovery and genotyping of single-nucleotide polymorphisms in the mouse. Nat Genet (2000) 4.66
An electrophoretic karyotype for Schizosaccharomyces pombe by pulsed field gel electrophoresis. Nucleic Acids Res (1987) 3.59
An STS-based radiation hybrid map of the human genome. Genome Res (1997) 3.57
Genomewide linkage analysis of stature in multiple populations reveals several regions with evidence of linkage to adult height. Am J Hum Genet (2001) 2.50
Genomewide linkage analysis of bipolar disorder by use of a high-density single-nucleotide-polymorphism (SNP) genotyping assay: a comparison with microsatellite marker assays and finding of significant linkage to chromosome 6q22. Am J Hum Genet (2004) 2.41
Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol Psychiatry (2010) 2.21
Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. Mol Psychiatry (2012) 2.20
Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder. Mol Psychiatry (2012) 2.09
Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry (2008) 2.07
SBE-TAGS: an array-based method for efficient single-nucleotide polymorphism genotyping. Proc Natl Acad Sci U S A (2000) 1.74
Editing of glutamate receptor subunit B pre-mRNA in vitro by site-specific deamination of adenosine. Nature (1995) 1.68
Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. Mol Psychiatry (2010) 1.63
Estrogen receptor: a prognostic factor in breast cancer. Cancer (1981) 1.51
Anaplastic carcinoma of the thyroid: a review of 84 cases of spindle and giant cell carcinoma of the thyroid. Cancer (1978) 1.45
A family-based study of common polygenic variation and risk of schizophrenia. Mol Psychiatry (2011) 1.44
Support for involvement of neuregulin 1 in schizophrenia pathophysiology. Mol Psychiatry (2005) 1.44
Genetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia. Mol Psychiatry (2005) 1.34
Hypothesis-driven candidate genes for schizophrenia compared to genome-wide association results. Psychol Med (2011) 1.30
Polygenic dissection of the bipolar phenotype. Br J Psychiatry (2011) 1.17
Replication of bipolar disorder susceptibility alleles and identification of two novel genome-wide significant associations in a new bipolar disorder case-control sample. Mol Psychiatry (2012) 1.16
Family-based association study of DTNBP1 in 6p22.3 and schizophrenia. Mol Psychiatry (2003) 1.12
Genome-wide scan in Portuguese Island families implicates multiple loci in bipolar disorder: fine mapping adds support on chromosomes 6 and 11. Am J Med Genet B Neuropsychiatr Genet (2004) 1.10
Meta-analysis reveals association between serotonin transporter gene STin2 VNTR polymorphism and schizophrenia. Mol Psychiatry (2005) 1.08
High-throughput polymorphism screening and genotyping with high-density oligonucleotide arrays. Genet Anal (1999) 1.07
Purification and characterization of a human RNA adenosine deaminase for glutamate receptor B pre-mRNA editing. Proc Natl Acad Sci U S A (1997) 1.05
Association at SYNE1 in both bipolar disorder and recurrent major depression. Mol Psychiatry (2012) 1.03
Hypokalemia with hypercalcemia. Prevalence and significance in treatment. Ann Intern Med (1977) 1.00
GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia. Mol Psychiatry (2010) 1.00
Parathyroid carcinoma: a clinical study of seven cases of functioning and two cases of nonfunctioning parathyroid cancer. Cancer (1982) 0.99
Further evidence of association between two NET single-nucleotide polymorphisms with ADHD. Mol Psychiatry (2007) 0.99
Microbial utilization of estuarine dissolved organic carbon: a stable isotope tracer approach tested by mass balance. Appl Environ Microbiol (1996) 0.99
Safety and efficacy of raltegravir in patients with HIV-1 and hepatitis B and/or C virus coinfection. HIV Med (2011) 0.98
Construction of a 750-kb bacterial clone contig and restriction map in the region of human chromosome 21 containing the progressive myoclonus epilepsy gene. Genome Res (1996) 0.98
In vivo anti-nuclear antibodies in epithelial biopsies in SLE and other connective tissue diseases. Clin Exp Immunol (1979) 0.95
Discrimination between 34S and 32S during bacterial metabolism of inorganic sulfur compounds. J Bacteriol (1986) 0.95
Investigation of variation in SNAP-25 and ADHD and relationship to co-morbid major depressive disorder. Am J Med Genet B Neuropsychiatr Genet (2007) 0.94
Multi-locus genome-wide association analysis supports the role of glutamatergic synaptic transmission in the etiology of major depressive disorder. Transl Psychiatry (2012) 0.94
Detecting large copy number variants using exome genotyping arrays in a large Swedish schizophrenia sample. Mol Psychiatry (2013) 0.93
Cis-acting regulation of brain-specific ANK3 gene expression by a genetic variant associated with bipolar disorder. Mol Psychiatry (2012) 0.92
High-resolution physical and transcriptional mapping of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy locus on chromosome 21q22.3 by FISH. Genome Res (1997) 0.91
Evidence for association of DNA sequence variants in the phosphatidylinositol-4-phosphate 5-kinase IIalpha gene (PIP5K2A) with schizophrenia. Mol Psychiatry (2006) 0.90
Behavioral and molecular actions of caffeine: focus on adenosine. J Psychiatr Res (1984) 0.90
Thyroid-stimulating hormone and prolactin levels in breast cancer. Arch Intern Med (1978) 0.88
Interprofessional postgraduate education in primary health care: is it making a difference? J Interprof Care (2005) 0.88
Transcriptional regulation of the MET receptor tyrosine kinase gene by MeCP2 and sex-specific expression in autism and Rett syndrome. Transl Psychiatry (2013) 0.85
Measurement of the CP asymmetry amplitude sin2beta with B0 mesons. Phys Rev Lett (2002) 0.83
Apolipoprotein E is a genetic risk factor for fetal iodine deficiency disorder in China. Mol Psychiatry (2000) 0.82
Ensuring the reliability of stable isotope ratio data--beyond the principle of identical treatment. Anal Bioanal Chem (2012) 0.81
Genomic survey of prepulse inhibition in mouse chromosome substitution strains. Genes Brain Behav (2009) 0.81
13C NMR evidence for pyruvate kinase flux attenuation underlying suppressed acid formation in Bacillus subtilis. Biotechnol Prog (2000) 0.81
Observation of CP violation in the B(0) meson system. Phys Rev Lett (2001) 0.80
Family-based association studies of COMT gene polymorphisms and schizophrenia in the Chinese population. Mol Psychiatry (2002) 0.79
Intermittent heparin flushing protocols. A standardization issue. J Intraven Nurs (1992) 0.78
Ammonia loss from rat proximal tubule in vivo: effects of luminal pH and flow rate. Am J Physiol (1988) 0.78
Genome-wide association study identifies SESTD1 as a novel risk gene for lithium-responsive bipolar disorder. Mol Psychiatry (2017) 0.76
"Do it yourself" reference materials for δ13C determinations by isotope ratio mass spectrometry. Anal Bioanal Chem (2013) 0.75
Activity attendance, hospital expectations, and suicide. Psychiatr Q (1984) 0.75
Measurement of the B0-B-0 oscillation frequency with inclusive dilepton events. Phys Rev Lett (2002) 0.75
Measurements of branching fractions and CP-violating asymmetries in B0-->pi+pi-, K+pi-, K+K- decays. Phys Rev Lett (2002) 0.75
Measurement of J/psi production in continuum e(+)e(-) annihilations near square root of s = 10.6 GeV. Phys Rev Lett (2001) 0.75
Measurement of branching fractions and search for CP-violating charge asymmetries in charmless two-body B decays into pions and kaons. Phys Rev Lett (2001) 0.75
Measurement of the branching fraction and CP content for the decay B0-->D(*+)D(*-). Phys Rev Lett (2002) 0.75
The 0.7 to 3.3 megabase chromosomes from Candida, Kluyveromyces, and Pichia provide accurate size standards for pulsed field gel electrophoresis. Electrophoresis (1993) 0.75
Measurement of the B--> J/psiK*(892) decay amplitudes. Phys Rev Lett (2001) 0.75
Rare B decays into states containing a J/psi meson and a meson with s(-)s quark content. Phys Rev Lett (2003) 0.75
Determinants of ammonia movements along the rat proximal convoluted tubule in vivo. Contrib Nephrol (1988) 0.75
Measurement of B0-B-0 flavor oscillations in hadronic B0 decays. Phys Rev Lett (2002) 0.75
Measurement of the decays B--> phiK and B--> phiK*. Phys Rev Lett (2001) 0.75
Contribution of superficial nephron segments to sodium excretion in experimental glomerulonephritis. Kidney Int (1989) 0.75
Measurement of CP-violating asymmetries in B0 decays to CP eigenstates. Phys Rev Lett (2001) 0.75
Measurements of the branching fractions of exclusive charmless B meson decays with eta(') or omega mesons. Phys Rev Lett (2001) 0.75
Impedance computed tomography algorithm and system. Appl Opt (1985) 0.75
Study of the rare decays B0-->D((*)+)(s)pi(-) and B0-->D((*)-)(s)K+. Phys Rev Lett (2003) 0.75
Measurement of the B(0) and B(+) meson lifetimes with fully reconstructed hadronic final states. Phys Rev Lett (2001) 0.75
Search for T and CP violation in B0-B-0 mixing with inclusive dilepton events. Phys Rev Lett (2002) 0.75
Measurement of the B(0) lifetime with partially reconstructed B(0)-->D(-)l(+)nu(l) decays. Phys Rev Lett (2002) 0.75
Measurement of B --> K*gamma branching fractions and charge asymmetries. Phys Rev Lett (2002) 0.75
Measurement of the B0-->J/psipi+pi- branching fraction. Phys Rev Lett (2003) 0.75
Trapping and sequence analysis of 1138 putative exons from human chromosome 18. Mol Psychiatry (2003) 0.75
Search for the rare decays B-->Kl(+)l(-) and B-->K(*)l(+)l(-). Phys Rev Lett (2002) 0.75
Search for the decay B0-->gammagamma. Phys Rev Lett (2001) 0.75